Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

Elens, Laure; J. Langman, Loralie; A. Hesselink, Dennis; Bergan, Stein; Jan A. R. Moes, Dirk; Molinaro, Mariadelfina; Venkataramanan, Raman; Lemaı̂tre, F.

doi:10.1097/ftd.0000000000000761

Public

Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

Published in Therapeutic Drug Monitoring • Apr 18, 2020

Authors:

Laure Elens

Loralie J. Langman

Dennis A. Hesselink

Abstract

BACKGROUND: COVID-19 is a novel infectious disease caused by the severe acute respiratory distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently emerging but none with universal consensus or proven efficacy. Solid organ transplant recipients are perceived to be at incr...

Subject

Medicine

Intensive care medicine

Context (archaeology)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!